Paroxetine is a highly potent and selective serotonin (5-HT) uptake inhibitor. It acts by binding to the serotonin transporter (SERT) with high affinity (Ki = 05 nM). In vitro paroxetine competitively inhibits the uptake of 5-HT by rat hypothalamic and cortical synaptosomes with only very weak effects on noradrenaline and dopamine uptake. Paroxetine is in clinical use for the treatment of depression, anxiety and other disorders.
Product Details
| Alternative Name: | Paxil®, Paroxetine . HCl . hemihydrate |
| |
| Formula: | C19H20FNO3 . HCl . 1/2 H2O |
| |
| MW: | 374.8 |
| |
| CAS: | 110429-35-1; 78246-49-8; 61869-08-7 (free base) |
| |
| Purity: | ≥98% (UHPLC) |
| |
| Appearance: | White to off-white crystalline solid. |
| |
| Solubility: | Soluble in DMSO (25mg/ml). |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | Ambient |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine: J. Fujishiro, et al.; Eur. J. Pharmacol.
454, 183 (2002),
Abstract;
Paroxetine: a review: M. Bourin, et al.; CNS Drug Rev.
7, 25 (2001),
Abstract;
Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites: M.J. Owens, et al.; J. Pharmacol. Exp. Ther.
283, 1305 (1997),
Abstract;
Full Text
Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor: D.R. Thomas, et al.; Psychopharmacol.
93, 193 (1987),
Abstract;
